Three competencies of the future Promomed top manager

Yuri Troyankin, Director of Human Resources and Organizational Development, named the three main competencies of the Promomed top manager, speaking at the Russian Pharmaceutical Forum. Semashko is in St. Petersburg. In his opinion, this is creativity, the ability to manage a mixed structure and a high level of emotional intelligence.

"In the current BANI world, which has replaced the era of VUCA, a person cannot be effective without creativity. Creativity is the first and necessary quality. The second quality is the ability to manage a mixed structure that unites people and technology. And the third thing is, of course, a high level of emotional intelligence. Without these qualities, effective interaction in flexible teams and in a hybrid environment will not work," shared Yuri Troyankin.

Promomed Group of Companies is actively developing, attracting new employees both to the management company and to production. Our experience shows that in recent months, the attractiveness of domestic companies in the pharmaceutical segment, such as Promomed and Biochemist (part of Promomed Group of Companies), has increased significantly in the eyes of candidates. The combination of an organization's stable market position and development projects is particularly attractive to candidates. Companies like Promomed have a unique opportunity to select highly qualified candidates, many of whom were not ready to consider transfers yesterday.

"When forming a team, primarily of managers," added Yuri Troyankin, —it is necessary to pay attention not only to the set of competencies, but also to the coincidence of personal value characteristics with corporate culture. Then the elements of engagement, interests, and unity of the value space will work. That is why Promomed Group's corporate competencies are related to the characteristics of the target corporate culture — values and mission."

The N.A. Semashko Russian Pharmaceutical Forum is the largest industry event. Every year, representatives of well-known pharmaceutical companies, regulators and experts gather at its site to discuss topical issues. This year, special attention was paid to the issues of working under sanctions, mechanisms for ensuring the stability of the pharmaceutical market and supporting drug accessibility, anti-crisis measures and prospects for the development of the domestic pharmaceutical industry.